Cardiovascular function and survival during severe systemic hypoxaemia: influence of glucose-potassium-insulin solution and of beta-blockade.
D000818:Animals; D001775:Blood Circulation; D001786:Blood Glucose; D004285:Dogs; D005947:Glucose / Q000627:therapeutic use*; D006973:Hypertension / Q000150:complications; D000860:Hypoxia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D007328:Insulin / Q000627:therapeutic use*; D011188:Potassium / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D012769:Shock / Q000209:etiology; D013610:Tachycardia / Q000150:complications; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D011433:Propranolol; D005947:Glucose; D011188:Potassium